Astrana Health, Inc. (ASTH) Q3 2026 earnings results
Astrana Health, Inc. (ASTH) reported Q3 2026 results on Nov 5, 2026, 4:10:40 PM ET: adjusted EPS $0.71 vs. $0.88 expected (miss by 19.0%); revenue $1.02B vs. $1.02B expected (beat by 0.3%). Outlook: The company provided guidance for total revenue and Adjusted EBITDA for the quarter ending December 31, 2026 and the year ending December 31, 2026.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.71 | $0.88 | Miss by 19.0% |
| Revenue | $1.02B | $1.02B | Beat by 0.3% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 5, 2026, 4:10:40 PM ET. Nexqual published them 96 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 7.1% from $956.05M.
Stock reaction
The results came out after the market closed. ASTH closed at $34.50 on November 6, 2026, down 11.6% from its $39.01 close on November 5, 2026 before the results. Latest: $31.72 as of 11:39 AM ET, −18.7% since the pre-release close.
Questions and answers
Did Astrana Health, Inc. beat earnings expectations?
No. Astrana Health, Inc. reported adjusted EPS of $0.71 against an average analyst estimate of $0.88 (miss by 19.0%), and revenue of $1.02B against $1.02B expected (beat by 0.3%).
What were Astrana Health, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.71 and revenue of $1.02B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 7.1% from $956.05M.
When did Astrana Health, Inc. report Q3 2026 earnings?
Nov 5, 2026, 4:10:40 PM ET, in an SEC 8-K filing (Item 2.02).
How did ASTH stock react to the earnings?
The results came out after the market closed. ASTH closed at $34.50 on November 6, 2026, down 11.6% from its $39.01 close on November 5, 2026 before the results. Latest: $31.72 as of 11:39 AM ET, −18.7% since the pre-release close.
What did Astrana Health, Inc. say about its outlook?
The company provided guidance for total revenue and Adjusted EBITDA for the quarter ending December 31, 2026 and the year ending December 31, 2026.
More on ASTH
ASTH stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 5, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:39 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:39 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt